MM Crossroads & Perspectives Webinar: October 14, 2026

Join us October 14, 2026 for a live, case-based discussion on integrating anti-CD38 therapy into first-line treatment for transplant-ineligible patients with multiple myeloma. Through a real-world case, interactive polling, and expert panel discussion, faculty will explore patient selection, transplant eligibility, treatment choice, and sequencing, with time for audience questions.

This one-hour webinar is designed for U.S.-based physicians, pharmacists, advanced practice providers, infusion nurses, and nurse navigators involved in multiple myeloma care.

Educational content from MM Crossroads & Perspectives™ will be available through InnoScholar.com following the live webinar, providing an opportunity to revisit the faculty discussion and explore the treatment considerations presented during the program.

Registration is for U.S.-based healthcare providers only.